Alaunos Therapeutics Inc (TCRT) Stock to return to profitability in the near future

Wells Fargo raised the price target for the Alaunos Therapeutics Inc (NASDAQ:TCRT) stock to “an Overweight”. The rating was released on October 04, 2022, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]